Diabetes Care 26:2392-2399, 2003
© 2003 by the American Diabetes Association, Inc.
Pathophysiology/Complications Original Article |
Racial Differences in Diabetic Nephropathy, Cardiovascular Disease, and Mortality in a National Population of Veterans
Bessie A. Young, MD, MPH1,2,3,
Charles Maynard, PHD1,4 and
Edward J. Boyko, MD, MPH1,2
1 Epidemiologic Research and Information Center, Department of Veterans Affairs Puget Sound Health Care System, Seattle, Washington
2 Division of General Internal Medicine, Department of Medicine, University of Washington, Seattle, Washington
3 Northwest Kidney Centers, Seattle, Washington
4 Department of Health Services, University of Washington, Seattle, Washington
Address correspondence and reprint requests to Bessie A. Young, MD, MPH, VA Puget Sound Health Care System, ERIC (152-E), 1660 S. Columbian Way, Seattle, WA 98108157. E-mail: youngb{at}u.washington.edu
OBJECTIVETo determine racial differences in the prevalence of diabetic nephropathy, cardiovascular disease (CVD), and risk of mortality in a national health care system.
RESEARCH DESIGN AND METHODSA longitudinal cohort study was conducted in 429,918 veterans with diabetes. Racial minority groups were analyzed for baseline differences in prevalence of early diabetic nephropathy, diabetic end-stage renal disease (ESRD) and CVD, and longitudinal risk of mortality compared with Caucasians.
RESULTSThe 429,918 patients identified with diabetes were of the following racial groups: Caucasian (56.2%), African American (15.3%), Asian (0.5%), Native American (0.4%), and unknown race (21.4%). Minority individuals were, on average, younger and less likely to have CVD but were more likely to have renal disease than Caucasians. After adjustment for age, sex, and economic status, African Americans (adjusted odds ratio [OR] = 1.3, 95% CI 1.21.4) and Native Americans (1.5, 1.12.1) were more likely to have early diabetic nephropathy than Caucasians. Diabetic ESRD was more likely to be present in African Americans (1.9, 1.92.0), Hispanics (1.4, 1.31.4), Asians (1.8, 1.52.1), and Native Americans (1.9, 1.52.3) than Caucasians. Concurrently, the adjusted OR of CVD in racial minority groups was 2749% less than in Caucasians, whereas the 18-month risk of mortality among people from most racial minority groups was 712% lower than in Caucasians.
CONCLUSIONSWe conclude that when access to care is comparable, microvascular complications, macrovascular disease, and subsequent death occur with different frequencies among various racial groups.
Abbreviations: BIRLS, Beneficiary Identification and Record Locator System COPD, chronic obstructive pulmonary disease CVD, cardiovascular disease ESRD, end-stage renal disease MRFIT, Multiple Risk Factor Intervention Trial VA, Veterans Affairs

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Cherrington, G. X. Ayala, H. Amick, J. Allison, G. Corbie-Smith, and I. Scarinci
Implementing the Community Health Worker Model Within Diabetes Management: Challenges and Lessons Learned From Programs Across the United States
The Diabetes Educator,
September 1, 2008;
34(5):
824 - 833.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Mehrotra, D. Kermah, L. Fried, S. Adler, and K. Norris
Racial Differences in Mortality Among Those with CKD
J. Am. Soc. Nephrol.,
July 1, 2008;
19(7):
1403 - 1410.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. D. Sequist, G. M. Fitzmaurice, R. Marshall, S. Shaykevich, D. G. Safran, and J. Z. Ayanian
Physician Performance and Racial Disparities in Diabetes Mellitus Care
Arch Intern Med,
June 9, 2008;
168(11):
1145 - 1151.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-J. Shin, H.-Y. Lin, C.-L. Wang, P.-J. Hsiao, and K.-D. Lin
Response to Comment on: Lin et al. (2007) SUMO4 M55V Variant Is Associated With Diabetic Nephropathy in Type 2 Diabetes: Diabetes 56:1177 1180
Diabetes,
August 1, 2007;
56(8):
e12 - e13.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Sugimoto, G. Grahovac, M. Zeisberg, and R. Kalluri
Renal Fibrosis and Glomerulosclerosis in a New Mouse Model of Diabetic Nephropathy and Its Regression by Bone Morphogenic Protein-7 and Advanced Glycation End Product Inhibitors
Diabetes,
July 1, 2007;
56(7):
1825 - 1833.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. E. Tchekneva, E. M. Rinchik, D. Polosukhina, L. S. Davis, V. Kadkina, Y. Mohamed, S. R. Dunn, K. Sharma, Z. Qi, A. B. Fogo, et al.
A Sensitized Screen of N-ethyl-N-nitrosourea-Mutagenized Mice Identifies Dominant Mutants Predisposed to Diabetic Nephropathy
J. Am. Soc. Nephrol.,
January 1, 2007;
18(1):
103 - 112.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Peralta, M. G. Shlipak, D. Fan, J. Ordonez, J. P. Lash, G. M. Chertow, and A. S. Go
Risks for End-Stage Renal Disease, Cardiovascular Events, and Death in Hispanic versus Non-Hispanic White Adults with Chronic Kidney Disease
J. Am. Soc. Nephrol.,
October 1, 2006;
17(10):
2892 - 2899.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. K. Kirk, R. B. D'Agostino Jr., R. A. Bell, L. V. Passmore, D. E. Bonds, A. J. Karter, and K.M. V. Narayan
Disparities in HbA1c Levels Between African-American and Non-Hispanic White Adults With Diabetes: A meta-analysis.
Diabetes Care,
September 1, 2006;
29(9):
2130 - 2136.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Volkova, W. McClellan, J. M. Soucie, and A. Schoolwerth
Racial disparities in the prevalence of cardiovascular disease among incident end-stage renal disease patients
Nephrol. Dial. Transplant.,
August 1, 2006;
21(8):
2202 - 2209.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Cherrington, G. X. Ayala, B. Sleath, and G. Corbie-Smith
Examining knowledge, attitudes, and beliefs about depression among latino adults with type 2 diabetes.
The Diabetes Educator,
July 1, 2006;
32(4):
603 - 613.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. I. Freedman, D. W. Bowden, M. M. Sale, C. D. Langefeld, and S. S. Rich
Genetic Susceptibility Contributes to Renal and Cardiovascular Complications of Type 2 Diabetes Mellitus
Hypertension,
July 1, 2006;
48(1):
8 - 13.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Galkina and K. Ley
Leukocyte Recruitment and Vascular Injury in Diabetic Nephropathy
J. Am. Soc. Nephrol.,
February 1, 2006;
17(2):
368 - 377.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. F. Brown, E. W. Gregg, M. R. Stevens, A. J. Karter, M. Weinberger, M. M. Safford, T. L. Gary, D. A. Caputo, B. Waitzfelder, C. Kim, et al.
Race, Ethnicity, Socioeconomic Position, and Quality of Care for Adults With Diabetes Enrolled in Managed Care: The Translating Research Into Action for Diabetes (TRIAD) study
Diabetes Care,
December 1, 2005;
28(12):
2864 - 2870.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M C Marshall Jr
Diabetes in African Americans
Postgrad. Med. J.,
December 1, 2005;
81(962):
734 - 740.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. H. Kuller, B. I. Freedman, L. E. Wagenknecht, D. W. Bowden, K. G. Keppel, J. N. Pearcy, J. S. Weissman, B. E. Akpunonu, A. B. Mutgi, S. A. Khuder, et al.
Trends in racial disparities in care.
N. Engl. J. Med.,
November 10, 2005;
353(19):
2081 - 2085.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. G. Bertoni, J. K. Kirk, L. D. Case, C. Kay, D. C. Goff Jr, K.M. V. Narayan, and R. A. Bell
The Effects of Race and Region on Cardiovascular Morbidity Among Elderly Americans With Diabetes
Diabetes Care,
November 1, 2005;
28(11):
2620 - 2625.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. K Kirk, R. A Bell, A. G Bertoni, T. A Arcury, S. A Quandt, D. C Goff Jr., and K M V. Narayan
Ethnic Disparities: Control of Glycemia, Blood Pressure, and LDL Cholesterol Among US Adults with Type 2 Diabetes
Ann. Pharmacother.,
September 1, 2005;
39(9):
1489 - 1501.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Gross, M. J. de Azevedo, S. P. Silveiro, L. H. Canani, M. L. Caramori, and T. Zelmanovitz
Diabetic Nephropathy: Diagnosis, Prevention, and Treatment
Diabetes Care,
January 1, 2005;
28(1):
164 - 176.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Breyer, E. Bottinger, F. C. Brosius III, T. M. Coffman, R. C. Harris, C. W. Heilig, K. Sharma, and for the AMDCC
Mouse Models of Diabetic Nephropathy
J. Am. Soc. Nephrol.,
January 1, 2005;
16(1):
27 - 45.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Young, W. J. Katon, M. Von Korff, G. E. Simon, E. H. B. Lin, P. S. Ciechanowski, T. Bush, M. Oliver, E. J. Ludman, and E. J. Boyko
Racial and Ethnic Differences in Microalbuminuria Prevalence in a Diabetes Population: The Pathways Study
J. Am. Soc. Nephrol.,
January 1, 2005;
16(1):
219 - 228.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. G. Araneta and E. Barrett-Connor
Subclinical Coronary Atherosclerosis in Asymptomatic Filipino and White Women
Circulation,
November 2, 2004;
110(18):
2817 - 2823.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Diabetes Association.
|
|
| |
|